Vaistinė plius - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 0 | 0 | - | 175,053 | 321,697 | 576,263 | 838,998 | 969,390 |
| Profit before tax | 0 | 0 | -7,109 | -46,441 | -40,336 | 19,201 | 9,655 | 27,261 |
| Net profit | 0 | 0 | -7,109 | -46,441 | -40,336 | 18,311 | 9,212 | 25,648 |
| Equity | 0 | 0 | -7,109 | -53,550 | -93,886 | -75,574 | -66,363 | -40,715 |
| Liabilities | 0 | 0 | 0 | 183,887 | 262,022 | 265,105 | 279,474 | 298,917 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 0 | 0 | 2,151 | 130,337 | 168,136 | 189,531 | 213,061 | 258,149 |
| Total assets | 0 | 0 | 2,151 | 130,337 | 168,136 | 189,531 | 213,061 | 258,149 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 19,486 | 22,424 | 24,227 |
| Social insurance contributions | - | - | - | - | - | 15,715 | 17,222 | 17,596 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | - | - | +83.8% | +79.1% | +45.6% | +15.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | -330.5% | -35.6% | -24.0% | 9.7% | 4.3% | 9.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | -26.5% | -12.5% | 3.2% | 1.1% | 2.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | -26.5% | -12.5% | 3.3% | 1.2% | 2.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | 36,853 | 62,264 | 119,228 | 209,750 | 187,623 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vaistinė plius - Social security debts
The company had no debts to Sodra
Vaistinė plius - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vaistine plius, UAB (code 125200579) is a Private Limited Liability Company operating in the retail sale of pharmaceutical products. In 2025, the company generated €969.4K in revenue, up 15.5% year on year and 68.2% over two years. Net profit rose to €25.6K in 2025 from €9.2K in 2024, after €18.3K in 2023, showing a recovery after the weaker 2024 result. The 2025 profit margin was 2.6%, compared with 1.1% in 2024 and 3.2% in 2023. The balance sheet remained leveraged: total assets increased to €258.1K in 2025, while liabilities reached €298.9K and equity stayed negative at €40.7K, although the equity deficit narrowed over the three-year period. Revenue per employee was €193.9K and profit per employee €5.1K in the latest year. Asset turnover was 3.76x and ROA was 9.9% in 2025. Because equity was negative, leverage-related ratios should be read with caution.